Comparison of three culture media for the establishment of melanoma cell lines

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cytotechnology (Dordrecht)

• Publication date

  2010-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10616-010-9286-9PMID 20730489PMCID PMC2993863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells

  2009cited by this paper
• MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency

  2008cited by this paper
• Relationship between responsiveness of cancer cells to Oncostatin M and/or IL‐6 and survival of stage III melanoma patients treated with tumour‐infiltrating lymphocytes

  2008cited by this paper
• Loss of oncostatin M receptor β in metastatic melanoma cells

  2007cited by this paper
• Loss of oncostatin M receptor beta in metastatic melanoma cells.

  2007cited by this paper
• In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum

  2005cited by this paper
• Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.

  2005cited by this paper
• Cancer Vaccine Potency: Is There a Dose/Response Relationship for Patient-Specific Vaccines and Clinical Outcomes?

  2005cited by this paper
• Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols.

  2005cited by this paper
• Adoptive-cell-transfer therapy for the treatment of patients with cancer

  2003cited by this paper
• Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell cultures.

  2003cited by this paper
• Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

  2002cited by this paper
• High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

  2001cited by this paper
• Expansion of Tumor-T Cell Pairs from Fine Needle Aspirates of Melanoma Metastases

  2000cited by this paper
• Dendritic cell-based immunotherapy of cancer.

  2000cited by this paper
• LFA‐3 co‐stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR‐independent activation signal

  1998cited by this paper
• Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

  1997cited by this paper
• HLA class II‐restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma‐infiltrating lymphocytes

  1995cited by this paper
• Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements

  1990cited by this paper
• Human tumor cells grown in fetal calf serum and human serum: Influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects

  1976cited by this paper

• Systematic Comparison of FBS and Medium Variation Effect on Key Cellular Processes Using Morphological Profiling

  2025cites this paper
• A novel patient-derived cutaneous melanoma cell line reveals key features of metastatic melanoma

  2025cites this paper
• Optimum Use of Human AB Serum for Monocyte-Differentiated Macrophages (MDMs) Isolated from Healthy Individuals

  2022cites this paper
• The dark side of foetal bovine serum in extracellular vesicle studies

  2022cites this paper
• Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value

  2021cites this paper
• Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

  2020cites this paper
• PD‐L1 expression by tumor cell lines: A predictive marker in melanoma

  2018cites this paper
• Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

  2018cites this paper
• A consensus introduction to serum replacements and serum-free media for cellular therapies.

  2017cites this paper
• Inhibitory effect of extracellular purine nucleotide and nucleoside concentrations on T cell proliferation.

  2016cites this paper
• Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

  2015cites this paper
• Comparative analysis of BRAF, NRAS and c‐KIT mutation status between tumor tissues and autologous tumor cell‐lines of stage III/IV melanoma

  2015cites this paper
• Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

  2014cites this paper
• Original article. Cinnamic aldehyde inhibits proliferation and invasion in a well-defined 3-dimensional culture of human cutaneous melanoma cells in tissue engineered-skin

  2013cites this paper
• Cinnamic aldehyde inhibits proliferation and invasion in a well-defined 3-dimensional culture of human cutaneous melanoma cells in tissue engineered-skin

  2013cites this paper
• Tissue Biomarkers in Melanoma Patients Treated with TIL

  2012cites this paper
• Human AB serum as an alternative to fetal bovine serum for endothelial and cancer cell culture.

  2012cites this paper
• Effective in vitro expansion of CD40-activated human B lymphocytes in a defined bovine protein-free medium.

  2011cites this paper
• Session 2 : Genetics of pigment cell transcription

  2010cites this paper